The GlyATL1 Polyclonal Antibody (PACO09495) is a valuable tool for researchers studying GlyATL1, a key enzyme involved in glycosylation processes. This antibody, produced in rabbits, exhibits high reactivity with human samples and is validated for use in Western blot applications. By targeting the GlyATL1 protein, researchers can effectively detect and analyze its expression in various cell types, making it ideal for investigations in the fields of glycobiology and cancer research.GlyATL1 plays a crucial role in glycosylation pathways, impacting various cellular processes such as protein folding, sorting, and function. Dysregulation of GlyATL1 has been implicated in diseases like cancer and congenital disorders affecting glycosylation.
By studying the function of GlyATL1, researchers can gain insights into the underlying mechanisms of these diseases and potentially identify novel therapeutic targets for intervention.Overall, the GlyATL1 Polyclonal Antibody is a valuable asset for researchers interested in elucidating the role of glycosylation in health and disease. Its high specificity and sensitivity make it an essential tool for advancing our understanding of GlyATL1 biology and its implications in various pathophysiological conditions.
GLYATL1 iso1: Acyltransferase which transfers an acyl group to the N- terminus of glutamine. Can use phenylacetyl-CoA as an acyl donor. Belongs to the glycine N-acyltransferase family. 2 isoforms of the human protein are produced by alternative splicing.Protein type: EC 2.3.1.68; TransferaseChromosomal Location of Human Ortholog: 11q12.1Cellular Component: mitochondrionMolecular Function: glycine N-acyltransferase activity; glutamine N-acyltransferase activityBiological Process: metabolic process
